These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 1855328)
21. Experience with subcutaneous erythropoietin in CAPD patients. Bailie GR; Plitnick R; Eisele G; Clement C; Rasmussen R Adv Perit Dial; 1991; 7():292-5. PubMed ID: 1680449 [TBL] [Abstract][Full Text] [Related]
22. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia]. Stojimirović B; Grujić-Adanja G Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238 [TBL] [Abstract][Full Text] [Related]
23. Erythropoietin associated hypertension among pediatric dialysis patients. Komatsu Y; Ito K Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845 [TBL] [Abstract][Full Text] [Related]
24. Epoetin omega for treatment of anemia in maintenance hemodialysis patients. Sikole A; Spasovski G; Zafirov D; Polenakovic M Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756 [TBL] [Abstract][Full Text] [Related]
25. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis]. Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643 [TBL] [Abstract][Full Text] [Related]
26. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD. Bunke M; Bartlett DK; Brier ME; Golper TA Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957 [TBL] [Abstract][Full Text] [Related]
27. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
28. Treatment of anaemia in CAPD patients with recombinant human erythropoietin. Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834 [TBL] [Abstract][Full Text] [Related]
29. Peritoneal dialysis efficiency in CAPD patients in treatment with rHuEPO. Vega N; Fernandez A; Hortal L; Macias M; Rodriguez JC; Plaza C; Perdomo M; Vega R; Palop L Adv Perit Dial; 1992; 8():467-70. PubMed ID: 1361850 [TBL] [Abstract][Full Text] [Related]
30. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis]. Litwin M; Boguszewska-Baczkowska A; Jelonek A Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665 [TBL] [Abstract][Full Text] [Related]
31. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency. Raja R; Bloom E; Johnson R; Goldstein M Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811 [TBL] [Abstract][Full Text] [Related]
32. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis. Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554 [TBL] [Abstract][Full Text] [Related]
33. [Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin]. Marusza W; Matuszkiewicz-Rowińska J; Tomik Z; Andrzejewski A; Rokicka M; Paszkowska M; Drygieniec D; Bobilewicz D; Zawadzka M; Abbas-Fatah A Pol Tyg Lek; 1995 Oct; 50(40-44):15-8, 31. PubMed ID: 8650050 [TBL] [Abstract][Full Text] [Related]
34. The efficiency of fractionated parenteral iron treatment in CAPD patients. Akcicek F; Ozkahya M; Cirit M; Ok E; Unsal A; Toz H; Celik A; Atabay G; Basci A Adv Perit Dial; 1997; 13():109-12. PubMed ID: 9360661 [TBL] [Abstract][Full Text] [Related]
35. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity. Bajo MA; Selgas R; Miranda B; Fernandez-Zamorano A; Borrego F; Romero JR; Caparros G; Riñon C; Sanchez Sicilia L Adv Perit Dial; 1991; 7():296-300. PubMed ID: 1680450 [TBL] [Abstract][Full Text] [Related]
36. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel. Yagil Y Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516 [TBL] [Abstract][Full Text] [Related]
37. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency]. Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients]. Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641 [TBL] [Abstract][Full Text] [Related]
39. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients. Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958 [TBL] [Abstract][Full Text] [Related]
40. Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis. Jonnalagadda V; Bloom EJ; Raja RM Adv Perit Dial; 1997; 13():113-5. PubMed ID: 9360662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]